A primary goal of managing atrial fibrillation is relief of symptoms that include dizziness, fatigue, palpitations, shortness of breath, and chest pain. Yet, it is symptomless in up to one-third of patients.
Women diagnosed with polycystic ovary syndrome are more likely to develop heart disease, diabetes, and other chronic conditions than those without the hormone disorder.
The FDA has approved Janssen Therapeutics’ darunavir and cobicistat (Prezcobix) for the treatment of human immunodeficiency virus (HIV-1) in combination with other antiretroviral agents for adults with no darunavir resistance-associated substitutions.
Continuing pharmacy operations during air conditioning outages have caused CVS to pay New Jersey more than $500,000 as part of a settlement.
The FDA today approved Bristol-Myers Squibb Company’s atazanavir and cobicistat for the treatment of HIV-1 infection in adults in combination with other antiretroviral agents.
Pharmacist collaboration with physicians during a national shortage of intravenous trimethoprim/sulfamethoxazole may have helped mitigate negative treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumonia.
Purdue Pharma has announced the US commercial launch of its extended-release hydrocodone bitartrate (Hysingla ER), an opioid analgesic indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment in patients for whom alternative treatment options are inadequate.
Pharmacy operations can be improved by investing in continuing education for pharmacy technicians.